RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Takeda Pharmaceutical Company Limited

A collection of news and information related to Takeda Pharmaceutical Company Limited published by this site and its partners.

Top Takeda Pharmaceutical Company Limited Articles see all

Displaying items 1-5
  • Takeda and Eli Lilly ordered to pay $9 billion over Actos drug

    Takeda and Eli Lilly ordered to pay $9 billion over Actos drug
    A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos.
  • Takeda, Eli Lilly must pay $9 billion in punitive damages over Actos

    Takeda, Eli Lilly must pay $9 billion in punitive damages over Actos
    Drugmakers Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a total of $9 billion in punitive damages after a Louisiana jury decided the companies did not disclose cancer risks of their diabetes medicine Actos. Japan-based Takeda said...

    Jury hits Takeda, Eli Lilly with $9-billion penalty

    Jury hits Takeda, Eli Lilly with $9-billion penalty
    TOKYO — A U.S. jury ordered Japanese drugmaker Takeda Pharmaceutical Co. and its U.S. counterpart, Eli Lilly and Co., to pay $9 billion in punitive damages over a diabetes medicine linked to cancer. The drug companies said Tuesday they will...

    U.S. venture gathers 10 drug makers to fight Alzheimer's, diabetes

    U.S. venture gathers 10 drug makers to fight Alzheimer's, diabetes
    Pfizer Inc., Eli Lilly & Co. and eight other large drug makers will partner with the U.S. government in a $230-million effort to identify new approaches to treat Alzheimer's, diabetes, lupus and arthritis. Data generated from the work will be made...

    Diet drug Contrave to get another shot at FDA approval

    Diet drug Contrave to get another shot at FDA approval
    The makers of the proposed weight-loss drug Contrave said this week they have taken a key first step in showing that the medication does not boost the heart and stroke risks of those taking it, and they announced plans to return to the Food and Drug...